Migdal Insurance & Financial Holdings’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-14
Closed -$4K 678
2021
Q4
$4K Hold
14
﹤0.01% 656
2021
Q3
$4K Hold
14
﹤0.01% 643
2021
Q2
$3K Hold
14
﹤0.01% 568
2021
Q1
$3K Buy
+14
New +$2.87K ﹤0.01% 656

Other funds holding RGEN

Migdal Insurance & Financial Holdings's RGEN Position: Q1 2022 in Review

Migdal Insurance & Financial Holdings sold out of Repligen (RGEN) in Q1 2022, closing a stake of 14 shares — an estimated $4K sold.

Migdal Insurance & Financial Holdings first reported a position in RGEN in Q1 2021 and held it in 4 quarters. The position peaked at $4K in Q4 2021. 451 funds tracked by Wall St. Rank hold RGEN as of Q1 2022.

  • Migdal Insurance & Financial Holdings reported no remaining Repligen position as of Q1 2022 after selling out during the quarter.
  • Migdal Insurance & Financial Holdings sold 14 Repligen shares in Q1 2022, an estimated $4K.
  • Migdal Insurance & Financial Holdings first reported a position in Repligen in Q1 2021 and held it in 4 quarters.
  • Migdal Insurance & Financial Holdings's Repligen position peaked at $4K in Q4 2021.
  • 451 funds tracked by Wall St. Rank held Repligen as of Q1 2022.

Based on Migdal Insurance & Financial Holdings's 13F filing for Q1 2022, filed 2 May 2022.